AlizaLeahLeiserMD

Obstetrics & Gynecology • New Brunswick, NJ

Gynecologic Oncology

Associate Professor of OB/GYN and Reproductive Sciences at Rutgers RWJ Medical School, Division Gynecologic Oncology Rutgers/CINJ, Director of Robotic Surgery Division Gynecologic Oncology

Join to view full profile

Dr. Leiser is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leiser's full profile

Already have an account?

Office
195 Little Albany Street
New Brunswick, NJ 08903
Phone+1 732-235-7258

Fax+1 732-235-9831

Education & Training

University of ChicagoResidency, Obstetrics and Gynecology, 1998 - 2002
Boston University Medical CenterResidency, Obstetrics and Gynecology, 1998 - 2002
Albert Einstein College of MedicineClass of 1998
Yale-New Haven Medical CenterFellowship, Gynecologic Oncology

Certifications & Licensure

NJ State Medical License 2014 - 2025
NY State Medical License 2009 - 2014
CT State Medical License 2006 - 2009
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3

Publications & Presentations

PubMed

4 citations
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.
Eugenia Girda, June Hou, David Nelson, Malcolm Finlayson, Alexandre Buckley de Meritens
International Journal of Gynecological Cancer. 2022-06-24
30 citations
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline.
Praveen Vikas, Hans Messersmith, Carolyn Compton, Lynette Sholl, Russell R Broaddus
Journal of Clinical Oncology. 2023-04-01
247 citations
Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells
Rui Chen, Ayesha B. Alvero, D-A Silasi, Michael G. Kelly, S Fest
Oncogene. 2008-08-07

Journal Articles

Ogilvie's Syndrome After Robotic-Assisted Radical Hysterectomy for Cervical Cancer
Theofano Orfanelli, MD; Stephanie Chung, MD; Adrian Kohut, MD; Darlene Gibbon, MD; Aliza Leiser MD, Journal of Minimally Invasive Gynecology, 7/2017

Lectures

Incorporation of HIPEC into a high volume ovarian cancer program: Initial results and outcomes.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Committees

Member, Robotics Steering Committee 2015 - Present